India’s drug pricing authority has given Abbott (NYSE:ABT) a year to pull its Xience Alpine drug-eluting stent from the market, according to an Indian Economic Times report. The company approached India’s National Pharmaceutical Pricing Authority nearly a month ago looking to withdraw the device, citing price caps set on stents earlier this year. Abbott first has to […]
Pharmaceuticals
Teva reintroduces generic Depo-Provera contraceptive in U.S.
Teva Pharmaceuticals (NYSE:TEVA) said today that it is reintroducing the generic equivalent to the Depo-Provera contraceptive in the U.S. The injectable medroxyprogesterone acetate suspension brought in $211 million in sales this year in the U.S., according to the Jerusalem-based pharma giant. “This reintroduction brings an additional product to a market that was previously lacking in options,” Hafrun […]
CDC campaign uses testimonials to fight prescription opioid epidemic
The Centers for Disease Control and Prevention today launched a campaign featuring real-life stories of people recovering from opioid-use disorder and people whose loved ones have died due to a prescription opioid overdose. The campaign was designed to boost awareness among Americans about the risks linked with prescription opioids. 91 people die everyday in the U.S. […]
Sanofi, Innovation Health to evaluate digital health solutions for Type II diabetes
Innovation Health and Sanofi (NYSE:SNY) said today that the companies are launching a pilot program to evaluate the impact of digital health solutions from One Drop and Common Sensing for people with Type II diabetes. The program hopes to enable pharmaceutical companies, tech companies and plan providers to work together to improve patient outcomes, according to […]
ASTRO ’17 Round-up: Novocure touts five-year results for Optune, chemo combo in newly-diagnosed glioblastoma patients
Novocure (NSDQ:NVCR) touted data today from the Phase III pivotal trial of its Optune device in combination with temozolomide for the treatment of newly-diagnosed glioblastoma. The analyses were presented at the American Society for Radiation Oncology’s 2017 annual meeting in San Diego. The company’s EF-14 trial showed unprecedented five-year survival results in patients with newly-diagnosed GBM, […]
Gelesis touts study of hydrogel obesity drug
PureTech subsidiary Gelesis today touted results from a pivotal weight-loss study of its obesity drug, Gelesis100. The study met one of its two primary endpoints, with 58% of adults in the treatment arm experiencing clinically-meaningful weight loss of 5% or more. Nearly twice as many adults lost 10% or more of the body weight in the […]
Keeping a patient’s lungs clean & expanded after surgery: a Drug Delivery Business News podcast
Every year, more than 1 million patients in the U.S. find themselves suffering from respiratory complications following surgery, according to Hill-Rom (NYSE:HRC). These complications come at a cost – to both the patient and the hospital. A respiratory problem can increase a patient’s time in the hospital by as much as 89%. More people die each […]
Grifols wins FDA nod for liquid formulation of replacement therapy for rare genetic disorder
Grifols (NSDQ:GRFS) said today that it won FDA approval for a liquid formulation of its alpha-1 antitrypsin, Prolastin-C Liquid, as a replacement therapy to treat alpha-1 antitrypsin deficiency. Prior to this approval, the company only offered Prolastin-C in a lyophilized format. The new formulation requires less preparation time and volume for infusion, according to Barcelona-based […]
Nestle plans to slash headcount at Galderma R&D center
(Reuters) – Nestle plans to cut up to 450 jobs at a Galderma research and development center in southern France, the Swiss company said on Thursday, as it seeks to make the underperforming skin health business more efficient. Galderma, which Nestle took over from its joint venture partner L’Oreal in 2014, will cut as many as […]
Steroid inhalers linked with hard-to-treat infections in COPD, asthma patients
A study that included more than 400,ooo people with COPD or asthma found that older people who use steroid inhalers for their condition are more likely to suffer lung infections caused by nontuberculous mycobacteria. The study was published in the European Respiratory Journal. “These infections are not particularly common but they are chronic and difficult to […]